Manuscripts
Showing 1552 manuscripts.
Osteonecrosis of the hip ( Legg-Calve-Perthes disease [LCPD]) in Human Immunodeficiency Virus-infected children.
Citation
Denise Gaughan, Lynne M. Mofenson, Michael Hughes, George Seage, Gregory Ciupak, James M. Oleske. Osteonecrosis of the hip ( Legg-Calve-Perthes disease [LCPD]) in Human Immunodeficiency Virus-infected children.. Pediatrics. 2002. 109: e74-4.Year
2002
Journal
Pediatrics
Mother to Child transmission in the United States of subtypes D and A/G human Immunodeficiency virus type 1.
Citation
Paul Krogstad, Susan H. Eshleman, Y. Z. Geng, Brooks Jackson, Michael Wantman, Bette T. Korber, Andrew A. Wiznia, George M. Johnson, Sharon Appelbaum Nachman, Paul Palumbo. Mother to Child transmission in the United States of subtypes D and A/G human Immunodeficiency virus type 1.. AIDS Research and Human Retroviruses. 2002. 18: 413-417.Year
2002
Journal
AIDS Research and Human Retroviruses
Lack of antitumor activity and intolerance of interleukin-4 in patients with advanced HIV disease and Kaposi's sarcoma
Citation
Steven A. Miles, Marcia A. Testa, Jie Huang, Michael Wade, Judith Carden, David Scadden. Lack of antitumor activity and intolerance of interleukin-4 in patients with advanced HIV disease and Kaposi's sarcoma. Journal of Interferon and Cytokine Research. 2002. 22: 1143-8.Year
2002
Journal
Journal of Interferon and Cytokine Research
The prevalence of pain in pediatric human immunodeficiency virus/acquired immunodeficiency syndrome as reported by participants in the Pediatric Late Outcomes Study (PACTG 219)
Citation
Richard D. Gelber, Steven Gortmaker, Denise Gaughan, Jane C. Lindsey, James M. Oleske, Rebecca Oyomopito, Michael Hughes, Carol Elgie, Michael T. Brady, Janice Hodge, George Seage, Barbara Nowak, Wayne Mathew Dankner, Bonnie Zimmer, Peter A. Selwyn, Yvonne J. Bryson, Lynne M. Mofenson, John W. Sleasman, Vincent J. Carey, Elizabeth Smith, Steven Gortmaker, George Seage, James M. Oleske, Denise Gaughan. The prevalence of pain in pediatric human immunodeficiency virus/acquired immunodeficiency syndrome as reported by participants in the Pediatric Late Outcomes Study (PACTG 219). Pediatrics. 2002. 109: 1144-1152.Year
2002
Journal
Pediatrics
Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged supression of plasma HIV-1 RNA in children.
Citation
A. Saitoh, Karen Hsia, Terence Fenton, Christine Powell, Cindy Christopherson, Courtney V. Fletcher, Stuart E. Starr, Stephen A. Spector. Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged supression of plasma HIV-1 RNA in children.. Journal of Infectious Diseases. 2002. 185: 1409-16.Year
2002
Journal
Journal of Infectious Diseases
T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy.
Citation
W. E. Naugler, Florence H. Yong, Vincent J. Carey, Joan Dragavon, Robert W. Coombs, Lisa M. Frenkel. T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy.. Journal of Infectious Diseases. 2002. 4: 448-55.Year
2002
Journal
Journal of Infectious Diseases
Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in HIV-1 infected children.
Citation
Joseph A. Church, Coleen Cunningham, Michael Hughes, Paul Palumbo, Lynne M. Mofenson, Patricia Mastrodonato DeLora, Elaine Margaret Smith, Andrew A. Wiznia, Lynette Purdue, Elizabeth Hawkins, Prakash Sista. Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in HIV-1 infected children.. Pediatric Infectious Disease Journal. 2002. 21: 653-9.Year
2002
Journal
Pediatric Infectious Disease Journal
Study
P1005
Pediatric HIV-1 infection: Advances and Remaining Challenges.
Citation
John L. Sullivan, Katherine Ruiz Luzuriaga. Pediatric HIV-1 infection: Advances and Remaining Challenges.. AIDS Clinical Review. 2002. 22-7.Year
2002
Journal
AIDS Clinical Review
Pharmacokinetic Characteristics of Ritonavir, Stavudine, Zidovudine, and Lamivudine in HIV-infected Children
Citation
Courtney V. Fletcher, Ram Yogev, Sharon Appelbaum Nachman, Andrew A. Wiznia, Stephen Ira Pelton, Kenneth McIntosh, Kenneth Stanley. Pharmacokinetic Characteristics of Ritonavir, Stavudine, Zidovudine, and Lamivudine in HIV-infected Children. Pharmacotherapy. 2002. 24: 453-9.Year
2002
Journal
Pharmacotherapy
Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir in pretreated children infected with human immunodeficiency virus type 1.
Citation
Paul Krogstad, Sophia S. Lee, George M. Johnson, Kenneth Stanley, James McNamara, John ( Jack ) Moye, Brooks Jackson, Rosaura M. Aguayo, Arry Dieudonne, Margaret Khoury, Hermann A. Mendez, Sharon Appelbaum Nachman, Andrew A. Wiznia. Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir in pretreated children infected with human immunodeficiency virus type 1.. Clinical Infectious Diseases. 2002. 34: 991-1001.Year
2002
Journal
Clinical Infectious Diseases